BAGSVAERD, DENMARK--(Marketwire - April 27, 2012) -
Company Announcement No 28 / 2012: http://hugin.info/2013/R/1606607/509371.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE [HUG#1606607]
Media:
Mike Rulis
Tel: (+45) 4442 3573
Email Contact
In North America:
Ken Inchausti
Tel: (+1) 609 786 8316
Email Contact
Investors:
Klaus Bülow Davidsen
Tel: (+45) 4442 3176
Email Contact
Lars Borup Jacobsen
Tel: (+45) 3075 3479
Email Contact
Frank Daniel Mersebach
Tel: (+45) 4442 0604
Email Contact
In North America
Jannick Lindegaard
Tel: (+1) 609 786 4575
Email Contact